⌘K

Login Start Free

Home/Filings/4/0001415889-24-001775

4//SEC Filing

NIVEN RALPH 4

Accession 0001415889-24-001775

CIK 0001798749other

View on SEC.gov Company Profile

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 6:00 PM ET

Size

5.5 KB

Accession

0001415889-24-001775

Insider Transaction Report

Form 4

Period: 2024-01-22

Aerovate Therapeutics, Inc.AVTE

Chief Development Officer

Transactions

Award
Stock Option (Right to Buy)
2024-01-22+66,586→ 66,586 total
Exercise: $20.00Exp: 2034-01-21→ Common Stock (66,586 underlying)

Footnotes (1)

[F1]This option shall vest and become exercisable in 48 substantially equal monthly installments, with the first installment vesting on February 22, 2024.

Documents

1 file

4
form4-01242024_060107.xmlPrimary

Issuer

Aerovate Therapeutics, Inc.

CIK 0001798749

Entity typeother

Related Parties

1

filerCIK 0001168060

Filing Metadata

Form type: 4
Filed: Jan 23, 7:00 PM ET
Accepted: Jan 24, 6:00 PM ET
Size: 5.5 KB

View on SEC.gov